🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Prostate Risk Or Radiology Assessment Non-inferiority Design, Upfront MRI or Risk Calculator in Men With Suspected Prostate Cancer

RecruitingNAAges 50 Years - 75 YearsMaleNorwegian University of Science and Technology
NCT07422597 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Thousands of men take a PSA test to investigate whether they have prostate cancer every year. For the vast majority, the test is normal and further investigations are not necessary. In others, the test is sufficiently elevated that men are referred for further investigations. Most men with an elevated PSA are offered an MRI examination of the prostate gland, and for some, a tissue sample of the prostate is also recommended if the suspicion of cancer is high enough. Although this comprehensive investigation reveals most clinically significant , or dangerous cases of cancer, many indolent, or "harmless" cancer cases are also detected, which would not have caused the man any harm during his lifetime (approximately 20% of all prostate cancer diagnoses diagnosed in current clinical practive). Cancer treatment is not recommended for such cases, but for many men, the diagnosis and subsequent fo

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * more than 10 years remaining life expectancy * Suspected localized prostate cancer * Suspicious DRE (cT2) * PSA 3-20 ng/ml Exclusion Criteria: * cT3 and/or cT4 (on DRE) * PSA \>20 ng/ml * Prior diagnosis of prostate cancer * Contraindications to MRI or to prostate biopsy * Medications known to affect serum PSA levels
💊

What it tests

  • European Study of screening for prostate cancer risk calculator
📍

Where

3 sites
Sykehuset Levanger
Levanger, Norway
Orkdal sjukehus
Orkanger, Norway
St Olavs Hospital
Trondheim, Norway
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy